C. Pribil

2.1k total citations
57 papers, 1.5k citations indexed

About

C. Pribil is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, C. Pribil has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 23 papers in Physiology and 11 papers in Epidemiology. Recurrent topics in C. Pribil's work include Asthma and respiratory diseases (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers) and Respiratory and Cough-Related Research (13 papers). C. Pribil is often cited by papers focused on Asthma and respiratory diseases (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers) and Respiratory and Cough-Related Research (13 papers). C. Pribil collaborates with scholars based in France, United Kingdom and Belgium. C. Pribil's co-authors include Abdelkader El Hasnaoui, I. Chanal, Michel Rugina, Damien Léger, I. Boucot, Isabella Annesi‐Maesano, B. Detournay, Françoise Neukirch, R. Jankowski and D. Huas and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and International Journal of Obesity.

In The Last Decade

C. Pribil

54 papers receiving 1.4k citations

Peers

Countries citing papers authored by C. Pribil

Since Specialization

Citations

This map shows the geographic impact of C. Pribil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Pribil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Pribil more than expected).

Fields of papers citing papers by C. Pribil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Pribil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Pribil. The network helps show where C. Pribil may publish in the future.

Co-authorship network of co-authors of C. Pribil

This figure shows the co-authorship network connecting the top 25 collaborators of C. Pribil. A scholar is included among the top collaborators of C. Pribil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Pribil. C. Pribil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme 2020 ·European Respiratory Journal ·Camille Taillé, Pascal Chanez, Gilles Devouassoux, A. Didier, Christophe Pison, Gilles Garcia, Jérémy Charriot, S. Bouée, (unknown), C. Pribil, Arnaud Bourdin, Marc Humbert	56
2	PIN105 DESCRIPTION OF PATIENTS HOSPITALIZED WITH MENINGOCOCCAL INFECTIONS IN FRANCE: AN ANALYSIS OF THE NATIONAL HEALTHCARE CLAIM(SNIIR-AM) DATABASE 2019 ·Value in Health ·Catherine Weil-Olivier, Muhamed‐Kheir Taha, Corinne Emery, Gaëlle Nachbaur, S. Bouée, (unknown), I. Bureau, C. Pribil	1
3	The Burden of Severe Asthma in France 2016 ·Value in Health ·Clémentine Nordon, Michel Aubier, Gabriel Thabut, Lamiae Grimaldi‐Bensouda, Billy Amzal, C. Pribil, Gaëlle Nachbaur, Roger Marthan	1
4	Limited treatment adaptation despite poor asthma control in asthma patients treated with inhaled corticosteroids 2015 ·Journal of Asthma ·Nicolás Roche, C. Pribil, Philippe Devillier, Éric Van Ganse, Stéphane Schück, (unknown), Jennifer M. Martin, Gaëlle Nachbaur, I. Boucot	7
5	Impact of Influenza B in France 2014 ·Value in Health ·Michel Lamure, (unknown), C. Pribil, (unknown), J. P. Auray, (unknown), (unknown)	1
6	Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France 2014 ·Value in Health ·(unknown), Fabrice Carrat, C. Pribil, François Bricaire, (unknown), J. Robert, A Lafuma	3
7	PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA Study 2011 ·Value in Health ·B. Garrigues, (unknown), Jean-Étienne Bazin, Isabelle Bardoulat, (unknown), (unknown), Frédérique Maurel, C. Pribil	1
8	Phénotype des patients asthmatiques selon le score dérivé de l’Asthma Control Test® 2010 ·Revue des Maladies Respiratoires ·Philippe Godard, I. Boucot, C. Pribil, D. Huas	3
9	Impact of Innate and Environmental Factors on Wheezing Persistence During Childhood 2010 ·Journal of Asthma ·J. Just, (unknown), Stéphanie Wanin, C. Pribil, A Grimfeld, Gérard Duru	21
10	Asthma patients' self-reported behaviours toward inhaled corticosteroids 2009 ·Respiratory Medicine ·Laurent Laforest, Abdelkader El Hasnaoui, C. Pribil, C. Ritleng, Liesl M. Osman, (unknown), (unknown), Éric Van Ganse	40
11	Control of asthma in children: still unacceptable? A French cross-sectional study 2009 ·Respiratory Medicine ·J. de Blic, I. Boucot, C. Pribil, Jacques Robert, D. Huas, Christophe Marguet	41
12	Lack of eosinophilia can predict remission in wheezy infants? 2008 ·Clinical & Experimental Allergy ·J. Just, (unknown), M. Feuilhade de Chauvin, C. Pribil, A Grimfeld, G. Duru	43
13	Nasal polyposis in France: impact on sleep and quality of life 2005 ·The Journal of Laryngology & Otology ·Élie Serrano, Françoise Neukirch, C. Pribil, R. Jankowski, Jean‐Michel Klossek, I. Chanal, Abdelkader El Hasnaoui	51
14	Prevalence of nasal polyposis in France: a cross‐sectional, case–control study 2005 ·Allergy ·(unknown), Françoise Neukirch, C. Pribil, R. Jankowski, É. Serrano, I. Chanal, Abdelkader El Hasnaoui	157
15	ER’Asthme, contrôle de l’asthme chez 16580 patients suivis en médecine générale 2005 ·La Presse Médicale ·Philippe Godard, D. Huas, (unknown), C. Pribil, I. Boucot	49
16	[A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France]. 2004 ·PubMed ·A Lafuma, Joseph Monsonégo, M. Moyal‐Barracco, C. Pribil	10
17	The SCOPE Study: Health-Care Consumption Related to Patients with Chronic Obstructive Pulmonary Disease in France 2004 ·Value in Health ·B. Detournay, C. Pribil, Michel Fournier, B. Housset, Gérard Huchon, D. Huas, Philippe Godard, (unknown), I. Chanal, (unknown), Isabelle Durand‐Zaleski	52
18	The burden of COPD in France: results from the confronting COPD survey 2003 ·Respiratory Medicine ·D Piperno, Gérard Huchon, C. Pribil, I. Boucot, Thomas Similowski	35
19	[Clinico-economic assessment of milnacipran in the prevention of depressive episodes]. 2000 ·PubMed ·A Lafuma, Roland Dardennes, Francis Fagnani, C. Pribil, (unknown), G Berdeaux	2
20	Economic Assessment of a Maintenance Treatment Strategy in Prevention of Recurrent Depressive Disorder 2000 ·Value in Health ·Roland Dardennes, A Lafuma, Francis Fagnani, C. Pribil, J.C. Bisserbe, G Berdeaux	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact